Abstract
Complete histopathologic tumor regression after neoadjuvant treatment is a well-known prognostic factor for survival among patients with adenocarcinomas of the esophagus and gastroesophageal junction. The aim of this international Delphi survey was to reach a consensus regarding the most useful tumor regression grading (TRG) system that could represent an international standard for histopathologic TRG grading of gastroesophageal carcinomas. Fifteen pathologists with special interest in esophageal and gastric pathology participated in the online survey. The initial questionnaire contained of 43 statements that addressed the following topics: (1) specimen processing, (2) gross examination, (3) cross sectioning, (4) staining, (5) Barrett's esophagus, (6) TRG systems, and (7) TRG in lymph node (LN). Participants rated the items using a 5-point Likert style scale and were encouraged to write comments for each statement. The expert panel recommended a 4-tiered TRG system for assessing the primary tumor: grade 1: No residual tumor (complete histopathologic tumor regression), grade 2: less than 10% residual tumor (near-complete regression), grade 3: 10%-50% residual tumor (partial regression), grade 4: greater than 50% residual tumor (...Continue Reading
References
Jan 6, 2000·Journal of Health Services Research & Policy·N BlackT Marteau
Feb 13, 2003·Journal of Advanced Nursing·Catherine Powell
Sep 23, 2003·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Jessica S DoningtonPeter C Pairolero
Sep 26, 2003·Cancer·Karen BeckerHeinz Höfler
Feb 19, 2005·Cancer·Lucian R ChirieacTsung-Teh Wu
Jul 28, 2005·Histopathology·R RyanK Sheahan
Oct 26, 2005·Annals of Surgery·Paul M SchneiderArnulf H Hoelscher
Nov 15, 2006·Gastroenterology·Prateek SharmaMichael Vieth
Mar 3, 2007·The Lancet Oncology·Val GebskiUNKNOWN Australasian Gastro-Intestinal Trials Group
Jul 30, 2008·Annals of Surgical Oncology·Andrew P BarbourB Mark Smithers
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Mar 3, 2009·International Journal of Radiation Oncology, Biology, Physics·Min Kyoung KimSung-Bae Kim
Feb 9, 2010·Annals of Surgical Oncology·Kenneth L MeredithRichard Karl
Nov 3, 2010·Annals of Surgery·D VallböhmerW Hofstetter
Sep 12, 2013·Annals of Surgery·Ashleigh M FrancisUNKNOWN University of Texas MD Anderson Esophageal Cancer Group
Sep 21, 2013·Annals of Surgery·Claire L DonohoeJohn V Reynolds
Oct 14, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Arnulf H HölscherJakob R Izbicki
Nov 8, 2014·Annals of Surgery·Arnulf H HölscherEfriede Bollschweiler
Jan 20, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F KlevebroM Nilsson
Mar 30, 2017·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·G TomaselloS Barni
Sep 16, 2018·Human Pathology·Andrianos TsekrekosMichael Vieth
Jan 13, 2019·Histopathology·Katharina PuetzUta Drebber
Apr 16, 2019·Lancet·Salah-Eddin Al-BatranUNKNOWN FLOT4-AIO Investigators
Mar 7, 2020·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·F KlevebroS Detlefsen
Citations
Jun 25, 2021·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·Michael Vieth, Markus F Neurath
Apr 27, 2021·The American Journal of Surgical Pathology·Deepti DhallGrace E Kim
Oct 7, 2021·Acta Oncologica·Rebecca K BottAndrew R Davies